News

Because the vaccination drive has picked up speed, the number of new infections and the number of people being admitted to hospital with COVID-19, are now both falling sharply. Therefore we are glad that we can take a step in relaxing measures. Although the current developments are good news, the virus is still around. The following measures are still current.

Our company is closed during Easter, Dutch King’s Day, Ascension Day and Pentecost.

Together with the BioCDx consortium, Future Diagnostics has been proudly working on the development of a miniaturized, reliable biosensing system for accurate and highly sensitive detection of protein cancer biomarkers, for the treatment monitoring of cancer disease and the therapeutics response.

At Future Diagnostics, we work on tomorrow’s healthcare projects. That is what makes our work fun and interesting. Especially at this time when healthcare is being tested like this. We take COVID-19 and our responsibility as an employer seriously in this process, while recruiting new colleagues is also important to us. That is why you can also apply at Future Diagnostics during times of COVID-19.

Last year was extraordinary. We would like to express our sincerest thanks for your continuous support. We cherish the safety and wellbeing of you, our colleagues, our clients and loved ones. We wish you a happy and healthy New Year and we hope to see you again in 2021.

DIAsource Immunoassays (Louvain-la-Neuve, Belgium), a BioVendor group company, has entered into a strategic agreement with Future Diagnostics (Wijchen, The Netherlands) under which Future Diagnostics will transfer all assets, with the exclusion of IP, related to Free 25OH Vitamin D ELISA product to DIAsource, securing its continued production and sales.

We hope that everyone is remaining healthy during the SARS-CoV-2 outbreak. At Future Diagnostics, we work on tomorrow’s healthcare projects. That is what makes our work interesting. Especially at this time when healthcare is being challenged like this.

We are very proud that Future Diagnostics Solutions is recognized by MedTech Outlook Magazine as TOP 10 In Vitro Diagnostic Solution Provider in Europe – 2020.